Global Gene Cloning Services Markets, 2021-2022 & 2031: Opportunities in the Rise in Demand for Gene and Cloning Services & Favorable Funding Scenario for Gene Synthesis and Cloning Services
23 mai 2022 05h03 HE | Research and Markets
Dublin, May 23, 2022 (GLOBE NEWSWIRE) -- The "Gene Cloning Services Market - A Global and Regional Analysis: Focus on Service, Gene Type, Application, End User, and Region - Analysis and Forecast,...
Metagenomic Sequencing Market Growth Opportunities Forecast to 2027 - NGS Data Analysis Using Big Data
23 mai 2022 04h03 HE | Research and Markets
Dublin, May 23, 2022 (GLOBE NEWSWIRE) -- The "Metagenomic Sequencing Market by Product & Services, Workflow, Technology, Application - Global Forecast to 2027" report has been added to...
Global Exosome Research Market Report 2022: Circulating Exosomal microRNAs (miRNAs) have Emerged as Valuable Biomarker Candidates
20 mai 2022 04h33 HE | Research and Markets
Dublin, May 20, 2022 (GLOBE NEWSWIRE) -- The "Global Exosome Research Market by Product and Services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers,...
Global Precision Medicine Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
17 mai 2022 08h18 HE | Research and Markets
Dublin, May 17, 2022 (GLOBE NEWSWIRE) -- The "Precision Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Proteona opens new laboratory in Singapore
10 mai 2022 21h01 HE | Proteona
SINGAPORE, May 10, 2022 (GLOBE NEWSWIRE) -- Proteona Pte. Ltd., a subsidiary of Singleron Biotechnologies, and a leader in single-cell multi-omics analysis, today announced the opening of a new...
The Third Annual Public Health Genetics Week is Around the Corner - May 23-27, 2022 BETHESDA, Md., May 10, 2022 (GLOBE NEWSWIRE) -- The National Coordinating Center for the Regional Genetics Network (NCC) is excited to announce that the third annual Public Health Genetics Week will...
Sema4_Logo2021_Primary_Gradient.png
Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 mai 2022 16h05 HE | Sema4
STAMFORD, Conn., May 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that, effective as of May 2, 2022, the...
Sema4_Logo2021_Primary_Gradient.png
Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms
02 mai 2022 07h45 HE | Sema4
Acquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S. Katherine Stueland, former President and CEO of GeneDx,...
Global Adoptive Cell Therapy Market (2022 to 2030) - Size, Share, Outlook, and Opportunity Analysis
28 avr. 2022 07h43 HE | Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "Adoptive Cell Therapy Market, by Type, By Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030"...
Outlook on the RNA Based Therapeutic Global Market to 2030 - Multifactorial Disease Targeting Presents Opportunities
28 avr. 2022 06h43 HE | Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "RNA Based Therapeutic Market by Disease Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...